Comment from Akhil Agrawal
AnonymousSupportBusiness
Summary: LifeProtect LLC, a U.S.-based holding company and manufacturer of personal protective equipment, supports the FDA's efforts to modernize and streamline the regulatory framework for NIOSH-approved respirators. They argue that while the draft guidance is a positive step, the FDA should provide greater clarity and harmonization regarding which agency (specifically suggesting OSHA) should oversee reusability and workplace-use claims for advanced antimicrobial respirators.
LifeProtect LLC appreciates the opportunity to comment on the Food and Drug Administration’s draft guidance entitled “Compliance Policy Regarding Premarket and Other Requirements for Certain NIOSH Approved Air-Purifying Respirators.
Our comments are included in the attached letter.
Respectfully submitted,
Akhil K. Agrawal
Chairman, Board of Directors
LifeProtect LLC
akhil@literacapital.com